# Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery

> **NCT00966654** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 12 (actual)

## Conditions studied

- CABG

## Interventions

- **DRUG:** Placebo
- **DRUG:** GLP-1 (7-36) amide

## Key facts

- **NCT ID:** NCT00966654
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2009-08
- **Final completion:** 2012-09
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** PI left JHU
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00966654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00966654, "Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00966654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*